L218-0239 Screening compound: N~1~-(3,5-dimethoxyphenyl)-2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetamide

L218-0239 Screening compound: N~1~-(3,5-dimethoxyphenyl)-2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetamide
L218-0239 Screening compound: N~1~-(3,5-dimethoxyphenyl)-2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L218-0239
N~1~-(3,5-dimethoxyphenyl)-2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L218-0239

Molecular Formula

C25H21N5O4 (C25 H21 N5 O4)

Compound Name

N~1~-(3,5-dimethoxyphenyl)-2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetamide

IUPAC name

N-(35-dimethoxyphenyl)-2-[13-oxo-11-(pyridin-4-yl)-1810-triazatricyclo[7.4.0.0^{27}]trideca-246911-pentaen-8-yl]acetamide

SMILES

COc1cc(NC(CN(c(cccc2)c2N23)C3=NC(c3ccncc3)=CC2=O)=O)cc(OC)c1

InChI

InChI=1S/C25H21N5O4/c1-33-18-11-17(12-19(13-18)34-2)27-23(31)15-29-21-5-3-4-6-22(21)30-24(32)14-20(28-25(29)30)16-7-9-26-10-8-16/h3-14H,15H2,1-2H3,(H,27,31)

InChI Key

RALQXSCABHLVBN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27236089

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.562

Distribution Coefficient, logD

2.562

Water Solubility, LogSw

-2.81

Polar Surface Area

75.749

Acid Dissociation Constant (pKa)

10.92

Base Dissociation Constant (pKb)

2.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.00

L218-0239 in Drug Discovery

Included in Screening Libraries

Antifungal Library (16415 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Agro:
  • Agro
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with L218-0239 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L218-0239?
Check Price and Availability of L218-0239, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L218-0239 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L218-0239
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L218-0239
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L218-0239 available by request